药品注册申请号:070541
申请类型:ANDA (仿制药申请)
申请人:TEVA
申请人全名:TEVA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 EPITOL CARBAMAZEPINE TABLET;ORAL 200MG No No AB 1986/09/17 1986/09/17 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/11/21 SUPPL-71(补充) Approval Labeling STANDARD
2020/02/27 SUPPL-64(补充) Approval Labeling STANDARD
2020/02/27 SUPPL-60(补充) Approval Labeling STANDARD
2015/01/20 SUPPL-58(补充) Approval Labeling STANDARD
2015/01/20 SUPPL-57(补充) Approval Labeling STANDARD
2014/03/10 SUPPL-55(补充) Approval Labeling STANDARD
2014/03/10 SUPPL-54(补充) Approval Labeling STANDARD
2013/07/09 SUPPL-49(补充) Approval Manufacturing (CMC)
2012/07/19 SUPPL-53(补充) Approval Labeling STANDARD
2011/05/31 SUPPL-52(补充) Approval Labeling
2009/11/04 SUPPL-47(补充) Approval Labeling
2008/03/17 SUPPL-46(补充) Approval Labeling
2002/12/05 SUPPL-45(补充) Approval Labeling
2002/08/01 SUPPL-43(补充) Approval Manufacturing (CMC)
2002/08/01 SUPPL-42(补充) Approval Manufacturing (CMC)
2002/05/08 SUPPL-44(补充) Approval Labeling
2000/05/01 SUPPL-41(补充) Approval Manufacturing (CMC)
1999/12/02 SUPPL-40(补充) Approval Manufacturing (CMC)
1999/12/02 SUPPL-39(补充) Approval Manufacturing (CMC)
1999/08/13 SUPPL-32(补充) Approval Labeling
1999/03/12 SUPPL-29(补充) Approval Manufacturing (CMC)
1999/02/12 SUPPL-31(补充) Approval Manufacturing (CMC)
1999/02/12 SUPPL-30(补充) Approval Manufacturing (CMC)
1998/06/15 SUPPL-27(补充) Approval Manufacturing (CMC)
1997/09/24 SUPPL-28(补充) Approval Labeling
1997/09/24 SUPPL-25(补充) Approval Labeling
1997/05/01 SUPPL-26(补充) Approval Labeling
1997/01/23 SUPPL-24(补充) Approval Manufacturing (CMC)
1996/08/16 SUPPL-23(补充) Approval Manufacturing (CMC)
1996/07/25 SUPPL-22(补充) Approval Manufacturing (CMC)
1995/02/09 SUPPL-21(补充) Approval Labeling
1993/02/18 SUPPL-19(补充) Approval Labeling
1992/01/23 SUPPL-18(补充) Approval Manufacturing (CMC)
1992/01/23 SUPPL-8(补充) Approval Manufacturing (CMC)
1991/12/05 SUPPL-13(补充) Approval Manufacturing (CMC)
1990/11/30 SUPPL-17(补充) Approval Labeling
1990/01/19 SUPPL-16(补充) Approval Labeling
1989/08/09 SUPPL-12(补充) Approval Labeling
1989/06/09 SUPPL-15(补充) Approval Manufacturing (CMC)
1989/04/07 SUPPL-11(补充) Approval Manufacturing (CMC)
1989/04/07 SUPPL-10(补充) Approval Labeling
1989/04/07 SUPPL-9(补充) Approval Manufacturing (CMC)
1988/03/11 SUPPL-6(补充) Approval Manufacturing (CMC)
1988/03/11 SUPPL-5(补充) Approval Labeling
1988/03/11 SUPPL-4(补充) Approval Manufacturing (CMC)
1987/12/17 SUPPL-1(补充) Approval Manufacturing (CMC)
1987/12/16 SUPPL-7(补充) Approval Manufacturing (CMC)
1987/11/09 SUPPL-3(补充) Approval Manufacturing (CMC)
1987/02/17 SUPPL-2(补充) Approval Labeling
1986/09/17 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:CARBAMAZEPINE 剂型/给药途径:TABLET;ORAL 规格:200MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
016608 001 NDA TEGRETOL CARBAMAZEPINE TABLET;ORAL 200MG Prescription Yes Yes AB Approved Prior to Jan 1, 1982 NOVARTIS
070541 001 ANDA EPITOL CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 1986/09/17 TEVA
074649 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 1996/10/03 TARO
075948 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2002/02/27 APOTEX INC
077272 002 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2005/12/07 TORRENT PHARMS
207798 002 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2020/04/15 UMEDICA
213284 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2022/08/22 UNICHEM
218221 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2024/02/16 BIONPHARMA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database